Teva Pharmaceutical Industries Limited

(NASDAQ:TEVA)
  Jun 30, 2008 Mar 31, 2008 Dec 31, 2007 Sep 30, 2007
Assets
Current Assets
Cash & Equivalents 2,484,000 2,509,000 1,488,000 1,508,000
Restricted Cash
Marketable Securities 803,000 693,000 1,387,000 1,149,000
Accounts Receivable 3,784,000 3,600,000 3,546,000 3,277,000
Loans Receivable
Other Receivable
Receivables 3,784,000 3,600,000 3,546,000 3,277,000
Raw Materials 759,000 725,000 663,000 583,000
Work in Progress 427,000 387,000 330,000 364,000
Purchased Components
Finished Goods 1,674,000 1,474,000 1,417,000 1,295,000
Other Inventories 47,000 58,000 30,000 56,000
Inventories Adjustments and Allowances
Inventories 2,907,000 2,644,000 2,440,000 2,298,000
Prepaid Expenses 845,000 1,046,000 998,000 900,000
Current Deferred Income Taxes
Other Current Assets
Total Current Assets 10,823,000 10,492,000 9,859,000 9,132,000
Land and Improvements 161,000
Building and Improvements 1,063,000
Machinery Furniture and Equipment 2,534,000
Construction in Progress
Other Fixed Assets 4,134,000 4,035,000 154,000 3,536,000
Total Fixed Assets 4,134,000 4,035,000 3,912,000 3,536,000
Gross Fixed Assets 4,134,000 4,035,000 3,912,000 3,536,000
Accumulated Depreciation and Depletion 1,397,000 1,397,000 1,397,000 1,110,000
Net Fixed Assets 2,737,000 2,638,000 2,515,000 2,426,000
Intangibles 1,917,000 1,955,000 1,919,000 1,927,000
Cost in Excess 8,670,000 8,676,000 8,407,000 8,293,000
Non Current Deferred Income Taxes
Other Non Current Assets 873,000 871,000 712,000 717,000
Total Non Current Assets 14,197,000 14,140,000 13,553,000 13,363,000
Total Assets 25,020,000 24,632,000 23,412,000 22,495,000
Liabilities
Current Liabilities
Accounts Payable 1,505,000 1,361,000 1,383,000 3,266,000
Notes Payable
Short Term Debt 1,429,000 2,032,000 1,841,000 1,952,000
Accrued Expenses
Accrued Liabilities
Deferred Revenues
Current Deferred Income Tax Liabilities
Other Current Liabilities 2,523,000 2,358,000 2,147,000
Total Current Liabilities 5,457,000 5,751,000 5,371,000 5,218,000
Non Current Liabilities
Long Term Debt 3,321,000 3,348,000 3,347,000 3,358,000
Capital Lease Obligations
Deferred Income Tax Liabilities 580,000 591,000 459,000 794,000
Other Non Current Liabilities 546,000 508,000 475,000 168,000
Minority Interest Liabilities 41,000 38,000 36,000 38,000
Preferred Securities of Subsidiary Trust Liabilities
Preferred Equity Outside Stock Equity
Total Non Current Liabilities 9,945,000 10,236,000 9,688,000 9,576,000
Total Liabilities 4,488,000 4,485,000 4,317,000 4,358,000
Shareholders' Equity
Preferred Stock Equity
Common Stock Equity 15,075,000 14,396,000 13,724,000 12,919,000
Common Par 46,000 46,000 46,000 46,000
Additional Paid in Capital 8,372,000 8,311,000 8,254,000 8,152,000
Cumulative Translation Adjustment
Retained Earnings 5,526,000 5,093,000 5,041,000 4,550,000
Treasury Stock -924,000 -982,000 -982,000 -982,000
Other Equity Adjustments 2,055,000 1,928,000 1,365,000 1,153,000
Total Capitalization 18,396,000 17,744,000 17,071,000 16,277,000
Cash Flow 2,283,000 2,267,000 2,473,000 2,327,000
Working Capital 5,366,000 4,741,000 4,488,000 3,914,000
Free Cash Flow 615,000 99,000 954,000 637,000
Invested Capital 18,396,000 17,744,000 17,071,000 16,277,000
Total Equity 15,075,000 14,396,000 13,724,000 12,919,000
Total Liabilities and Stock Equity 25,020,000 24,632,000 23,412,000 22,495,000